Literature DB >> 23687354

The mutation, a key determinant of phenotype in ADPKD.

Peter C Harris, Katharina Hopp.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23687354     DOI： 10.1681/ASN.2013040417

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  12 in total

1.  Targeted rescue of a polycystic kidney disease mutation by lysosomal inhibition.

Authors:  Alexis Hofherr; Claudius J Wagner; Terry Watnick; Michael Köttgen
Journal:  Kidney Int       Date:  2016-01-06       Impact factor: 10.612

2.  Comprehensive genetic testing approach for major inherited kidney diseases, using next-generation sequencing with a custom panel.

Authors:  Takayasu Mori; Kazuyoshi Hosomichi; Motoko Chiga; Shintaro Mandai; Hirofumi Nakaoka; Eisei Sohara; Tomokazu Okado; Tatemitsu Rai; Sei Sasaki; Ituro Inoue; Shinichi Uchida
Journal:  Clin Exp Nephrol       Date:  2016-02-26       Impact factor: 2.801

Review 3.  Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease.

Authors:  Peter C Harris; Vicente E Torres
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

Review 4.  Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.

Authors:  Emilie Cornec-Le Gall; Vicente E Torres; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2017-10-16       Impact factor: 10.121

Review 5.  Adhesion GPCRs as a paradigm for understanding polycystin-1 G protein regulation.

Authors:  Robin L Maser; James P Calvet
Journal:  Cell Signal       Date:  2020-04-16       Impact factor: 4.315

6.  The Future of Polycystic Kidney Disease Research--As Seen By the 12 Kaplan Awardees.

Authors:  Corinne Antignac; James P Calvet; Gregory G Germino; Jared J Grantham; Lisa M Guay-Woodford; Peter C Harris; Friedhelm Hildebrandt; Dorien J M Peters; Stefan Somlo; Vicente E Torres; Gerd Walz; Jing Zhou; Alan S L Yu
Journal:  J Am Soc Nephrol       Date:  2015-05-07       Impact factor: 10.121

7.  Diagnosis of autosomal dominant polycystic kidney disease using efficient PKD1 and PKD2 targeted next-generation sequencing.

Authors:  Daniel Trujillano; Gemma Bullich; Stephan Ossowski; José Ballarín; Roser Torra; Xavier Estivill; Elisabet Ars
Journal:  Mol Genet Genomic Med       Date:  2014-05-23       Impact factor: 2.183

Review 8.  The Genetic and Cellular Basis of Autosomal Dominant Polycystic Kidney Disease-A Primer for Clinicians.

Authors:  Adrián Cordido; Lara Besada-Cerecedo; Miguel A García-González
Journal:  Front Pediatr       Date:  2017-12-18       Impact factor: 3.418

Review 9.  Advances in Autosomal Dominant Polycystic Kidney Disease: A Clinical Review.

Authors:  Niloofar Nobakht; Ramy M Hanna; Maha Al-Baghdadi; Khalid Mohammed Ameen; Farid Arman; Ehsan Nobahkt; Mohammad Kamgar; Anjay Rastogi
Journal:  Kidney Med       Date:  2020-02-22

10.  A randomized phase 1b cross-over study of the safety of low-dose pioglitazone for treatment of autosomal dominant polycystic kidney disease.

Authors:  Bonnie L Blazer-Yost; Robert L Bacallao; Bradley J Erickson; Michelle L LaPradd; Marie E Edwards; Nehal Sheth; Kim Swinney; Kristen M Ponsler-Sipes; Ranjani N Moorthi; Susan M Perkins; Vicente E Torres; Sharon M Moe
Journal:  Clin Kidney J       Date:  2021-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.